1. Editorial: gastrointestinal safety of COX‐2 selective and nonselective NSAIDs—the impact of the PRECISION trial. Authors' reply. Issue 11 (17th May 2018) Authors: Yeomans, N. D.; Graham, D. Y. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 11(2018) Page Start: 1546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Editorial: gastrointestinal safety of COX‐2 selective and nonselective NSAIDs—the impact of the PRECISION trial. Authors' reply. Issue 11 (June 2018) Authors: Yeomans, N. D.; Graham, D. Y. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 11(2018) Page Start: 1546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Editorial: quadruple therapy for H. pylori eradication is better than triple therapy – authors' reply. Issue 7 (4th March 2015) Authors: Molina‐Infante, J.; Graham, D. Y.; Gisbert, J. P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 41:Issue 7(2015) Page Start: 695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Editorial: recurrence of Helicobacter pylori infection—still the same after all these years… Authors' reply. Issue 1 (11th December 2017) Authors: Hu, Y.; Wan, J.‐H.; Li, X.‐Y.; Zhu, Y.; Graham, D. Y.; Lu, N.‐H. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 1(2018) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Letter: bismuth, levofloxacin, amoxicillin, PPI quadruple therapy is not an effective first or second line regimen in the presence of levofloxacin resistance. Issue 11 (June 2015) Authors: Graham, D. Y.; Lu, H. Journal: Alimentary pharmacology & therapeutics Issue: Volume 41:Issue 11(2015) Page Start: 1220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Letter: clarithromycin dose for H. pylori therapy remains unresolved. Issue 5 (September 2015) Authors: Graham, D. Y.; Gisbert, J. P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 42:Issue 5(2015) Page Start: 631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Letter: gastric cancer and pernicious anaemia – often Helicobacter pylori in disguise. Issue 7 (5th March 2013) Authors: Rugge, M.; Fassan, M.; Pizzi, M.; Graham, D. Y. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 7(2013) Page Start: 764 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Letter: questions regarding the diagnostic performance of serum assays for atrophic gastritis. Issue 11 (3rd November 2017) Authors: Graham, D. Y. Journal: Alimentary pharmacology & therapeutics Issue: Volume 46:Issue 11/12(2017) Page Start: 1117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial. Issue 11 (17th April 2018) Authors: Yeomans, N. D.; Graham, D. Y.; Husni, M. E.; Solomon, D. H.; Stevens, T.; Vargo, J.; Wang, Q.; Wisniewski, L. M.; Wolski, K. E.; Borer, J. S.; Libby, P.; Lincoff, A. M.; Lüscher, T. F.; Bao, W.; Walker, C.; Nissen, S. E. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 11(2018) Page Start: 1453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Systematic review with meta‐analysis: the global recurrence rate of Helicobacter pylori. Issue 9 (11th September 2017) Authors: Hu, Y.; Wan, J.‐H.; Li, X.‐Y.; Zhu, Y.; Graham, D. Y.; Lu, N.‐H. Journal: Alimentary pharmacology & therapeutics Issue: Volume 46:Issue 9(2017) Page Start: 773 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗